RxDoctor Payments Data

Johnnie Cummings, MD

Internal Medicine · Batesville, MSNPI 1972501815

Payments from drug & device makers

$1,588in general payments, 2019–2025

Across 86 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$368
  • Gilead$212
  • Viiv Healthcare Company$165
  • Merck$163
  • AstraZeneca$121
  • AbbVie$121
  • plus $437 from 12 others

What the payments were for

  • Food & beverage$1,53497%
  • Education$553%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,588 in reported general payments places this provider in the 70th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$349
Medicare patients
14
Services billed
129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide109$74,194
TrulicityDulaglutide31$59,920
EliquisApixaban49$57,432
JardianceEmpagliflozin55$53,505
FarxigaDapagliflozin Propanediol36$44,160
OzempicSemaglutide32$39,238
PrezcobixDarunavir/Cobicistat12$33,099
TivicayDolutegravir Sodium12$30,049
Tresiba Flextouch U-200Insulin Degludec25$29,827
JanuviaSitagliptin Phosphate23$21,598
XareltoRivaroxaban22$20,425
Xigduo XrDapaglifloz Propaned/Metformin18$15,750
RybelsusSemaglutide11$9,422
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen311$7,745
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog20$6,315

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$121$74,194109 claims
Lilly USA, LLCTrulicity$89$59,92031 claims
Johnson & JohnsonPrezcobix, Xarelto$13$53,52334 claims
Boehringer IngelheimJardiance$30$53,50555 claims
Novo NordiskOzempic, Rybelsus$368$48,66043 claims
AstraZenecaFarxiga$121$44,16036 claims
Viiv Healthcare CompanyTivicay$165$30,04912 claims
MerckJanuvia$163$21,59823 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Batesville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →